Flag Ship Acquisition (NASDAQ:ETHZ) executives, speaking during a Forum Markets presentation hosted by Force Family Office, outlined a strategy centered on acquiring cash-generating real-world assets while maintaining the option to fractionalize and tokenize those assets as the market develops. Joh
Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
(Bloomberg) -- Chipotle Mexican Grill Inc. removed jalapeños from multiple stores in Minnesota after learning the peppers may be linked to a salmonella outbreak in the state that’s sickened 110 people.Most Read from BloombergBeer Dynasty Families Sell €731 Million Stake in AB InBevChina’s AI Blitz Creates ‘Death Zone’ for Rival US Model MakersTaco Bell Met With Michigan on Parasite Weeks Before RecallApple’s New CEO Taps Retired Hardware Executive for Management TeamQatar, Bessent Signal Progres
The acquisition, which was first announced in June, brings Vibe.co into Walmart Connect, Walmart's connected TV advertising platform.
SRX Global (AMEX:SRXH) disclosed an investment in Vistagen Therapeutics (NASDAQ:VTGN) and said it intends to engage with the company’s leadership and board on potential shareholder value initiatives. Key Investor TakeawaysSRX Global (AMEX:SRXH) acquired a stake in Vistagen Therapeutics (NASDAQ:VTGN).
Citi has told clients that a large chunk of deal risk is already in AstraZeneca PLC's (LSE:AZN, NASDAQ:AZN) share price after Monday's sharp fall, while Deutsche Bank sees clear parallels with the drugmaker's Alexion acquisition five years ago. The two notes are the second-day response to a...
Hims and Hers has 2.6 million subscribers, a battered stock price, and a CEO buying shares instead of signaling an exit. That combination puts a very specific list of giants on alert, and only one of them is a clean fit.

Ex-Uber founder and CEO Travis Kalanick is back in the ride-hail business — but this time in the skies.

Ex-Uber founder and CEO Travis Kalanick is back in the ride-hail business — but this time in the skies.
IREN now controls more of the stack between its data centers and customer workloads, extending its AI cloud platform into orchestration and enterprise support.
Even if a megamerger fails to materialize, investors stand to benefit from a wave of M&A activity in the biopharma sector.
Chinese robot maker Unitree Technology is expected to be valued at more than 50 billion yuan ($7.4 billion) after its planned Shanghai IPO, according to a report by Citic Securities, which is sponsoring the initial public offering. Citic Securities expected the Hangzhou-based company to be worth 50.6 billion to 55.9 billion yuan six to 12 months after listing later this month. The valuation report, distributed to investors and seen by Reuters, is largely seen as guidance ahead of Wednesday's IPO price enquiry.
SpaceX (NASDAQ:SPCX) is due to publish its quarterly results after the close of trading on Tuesday, marking the company’s first earnings report since its highly anticipated stock market debut. The release is expected to provide investors with a clearer picture of whether the company’s financial performance supports the ambitious growth expectations that accompanied its listing, particularly as it continues to invest heavily in artificial intelligence and space technologies.
Robinhood (NASDAQ:HOOD) is seeking to raise up to $200 million through the U. S.
The transaction was first announced in March, when Mastercard signed an agreement to acquire BVNK for up to $1.8bn.
Big drug companies have been buying scrappy biotechs to expand their pipelines, but the potential megamerger between AstraZeneca and Bristol Myers Squibb could flip that script.
Elon Musk’s net worth continued to plunge this week as shares of his two flagship companies, Tesla and SpaceX, retreated amid swirling merger speculation, with traders also positioning ahead of SpaceX’s upcoming earnings report. Elon Musk Net Worth is Down...
Mastercard finally closed its acquisition of London-based stablecoin infrastructure provider BVNK on August 3, 2026. If you have ever wondered what happens when the plumbing of global finance decides to move inside the house, this is your answer. It is not just another corporate press release about a strategic partnership; it is the moment the […]
Another SMR stock is expected to make its public debut.
The UK drugmaker is reportedly talking to Bristol Myers Squibb about a nearly $400 billion tie-up, but investors are struggling to diagnose the logic.
The fund holds 80 private companies and focuses on Y Combinator startups, with shares expected to list on the NYSE on August 13
Rocket Lab is rapidly transforming from a launch company into a diversified space business, positioning it for profits and strong free cash flow as early as next year.
As stocks like Eli Lilly, Twilio, Hinge Health and more move ahead of earnings report, pay attention to these chart lines.
The FTSE 100 index closed down 10.35 points, 0.1%, at 10,857.70.
BMY surged roughly 6% in premarket trading on the news before fading; the stock is now trading near flat. The asymmetric price reaction captures the market's immediate verdict: AZN shareholders see a value-destructive deal, while BMY holders see a potential premium exit.
Space Exploration Technologies or SpaceX's (SPCX) current valuation appears attractive after shares
European stock markets closed mostly higher in Monday trading as the Stoxx Europe gained 0.4%, Germa
Also, the e-bike startup spun off from Rivian Automotive Inc., will reportedly begin delivering its first e-bikes next week, ending months of delays that pushed back its original spring launch. The Launch Edition of its $4,500 TM-B e-bike has started...
The company's stock took quite a body blow after it reported first-quarter earnings.
The firm uses AI and machine-learning models to detect signs of coercion or manipulation in digital transactions, helping banks distinguish criminal activity from legitimate ones in real time.
AstraZeneca stock took a nosedive Monday amid reports it's mulling a mega-merger with Bristol Myers Squibb.